Clinical Trial Update: A Study of OGX-011/Gemcitabine/Platinum-Based Regimen in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes results from a Phase 1/2 study evaluating OGX-011 in combination with gemcitabine and a platinum-based regimen for Stage II…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• OGX-011 (custirsen)
• Platinum-based chemotherapy (platinum-based chemotherapy)

Snippet

Sponsor: Achieve Life Sciences | Conditions: Non-small Cell Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-01-10